Financial Calendar & AGM

Annual General Meetings

2023

Generalforsamling 2023
27. april 2023
Annual General Meeting 2023
27 April 2023
Indkaldelse
Tilmelding/Fuldmagtsblanket
Vedtægter
Årsrapport 2022
Vederlagsrapport 2022
Referat fra Generalforsamlingen
Convening notice
Request for admission card/proxy
Articles of Association
Annual Report 2022
Remuneration Report 2022
Finansielle rettigheder
Aktierne er udstedt i papirløs form gennem og registreret hos VP Securities A/S. Finansielle rettigheder udøves gennem VP Securities A/S. Rettigheder vedrørende aktierne skal anmeldes til VP Securities A/S efter de herom gældende regler.
Financial rights
The shares have been issued in dematerialized form by and are registered with VP Securities A/S. Financial rights are exercised through VP Securities A/S. Rights over the shares shall be notified to VP Securities A/S in accordance with applicable rules.

2022

Generalforsamling 2022
28. april 2022
Annual General Meeting 2022
28 April 2022
Indkaldelse
Tilmelding/Fuldmagtsblanket
Vedtægter
Årsrapport 2021
Vederlagsrapport 2021
Referat fra Generalforsamlingen
Convening notice
Request for admission card/proxy
Articles of Association
Annual Report 2021
Remuneration Report 2021
Finansielle rettigheder
Aktierne er udstedt i papirløs form gennem og registreret hos VP Securities A/S. Finansielle rettigheder udøves gennem VP Securities A/S. Rettigheder vedrørende aktierne skal anmeldes til VP Securities A/S efter de herom gældende regler.
Financial rights
The shares have been issued in dematerialized form by and are registered with VP Securities A/S. Financial rights are exercised through VP Securities A/S. Rights over the shares shall be notified to VP Securities A/S in accordance with applicable rules.

2021

Generalforsamling 2021
27. april 2021
Annual General Meeting 2021
27 April 2021
Indkaldelse
Tilmelding/Fuldmagtsblanket
Vedtægter
Årsrapport 2020
Vederlagsrapport 2020
Referat fra Generalforsamlingen
Convening notice
Request for admission card/proxy
Articles of Association
Annual Report 2020
Remuneration Report 2020
Finansielle rettigheder
Aktierne er udstedt i papirløs form gennem og registreret hos VP Securities A/S. Finansielle rettigheder udøves gennem VP Securities A/S. Rettigheder vedrørende aktierne skal anmeldes til VP Securities A/S efter de herom gældende regler.
Financial rights
The shares have been issued in dematerialized form by and are registered with VP Securities A/S. Financial rights are exercised through VP Securities A/S. Rights over the shares shall be notified to VP Securities A/S in accordance with applicable rules.

900+

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 3 products:

Quick Triage

A Point of Care Solution

TurbiLatex

For Automated Systems

ELISA Assay

Clinical and Research

suPAR is used in clinical routine in 48 hospitals

48 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling.
This period covers January 1, 2022, until December 31, 2022. Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates